Cited by 67Atrial Fibrillation Management and OutcomesPharmacogenetics and Drug MetabolismPharmaceutical Practices and Patient Outcomes

The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients

Open access
Hauta-Aho, Milka, Tirkkonen, Tuire, Vahlberg, Tero, Laine, Kari·2009·Annals of Medicine

Abstract

BACKGROUND: Bleeding is a serious adverse drug reaction associated with warfarin therapy, often induced by interacting co-medication. METHODS: We investigated the frequency and clinical consequences of warfarin drug interactions utilizing medical records of 6,772 warfarin-treated in-patients of Turku University Hospital. RESULTS: A total of 48% of warfarin-treated in-patients were exposed to interacting co-medication. Adjusted odds ratio (OR) for bleeding was highest for cytochrome P450 2C9 (CYP2C9) inhibitors (OR 3.6; 95% confidence interval (CI) 2.4-5.6). Non-selective non-steroidal anti-inflammatory drugs (NSAID) and coxibs were associated with a bleeding risk of a similar magnitude (OR 2.6; 95% CI 1.6-4.2 and OR 3.1; 95% CI 1.4-6.7, respectively). Selective serotonin re-uptake inhibitors (SSRI) were associated with a remarkably higher bleeding risk than non-SSRIs (OR 2.6; 95% CI 1.5-4.3 and OR 1.2; 95% CI 0.3-4.3, respectively). Odds ratio for bleeding in the platelet aggregation inhibitor group was 1.6 (95% CI 0.8-3.1). CONCLUSION: We conclude that co-medication in warfarin-treated in-patients is common and should be carefully evaluated to decrease the bleeding risk associated with warfarin therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/07853890903186168

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Lipsky PE. Rheumatoid arthritis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill; 2001. p. 1928Á37.
  2. Adamson JW, Longo DL. Anemia and polycythemia. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medi- cine, 15th ed. New York: McGraw-Hill, 2001. p. 348Á54.

Cited by

Sorted by citations

Authors
Hauta-Aho, M., Tirkkonen, T., Vahlberg, T., & Laine, K.
Affiliations
  • University of Turku (FI)
  • Turku University Hospital (FI)
Venue
Annals of Medicine
Published
2009-01
Volume
41
Issue
8
Pages
619-628
ISSN
  • 0785-3890 (ISSN-L)
  • 1365-2060
OpenAlex
W1978773847
Cited by
67
References
28
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 8 · 2014: 4 · 2013: 5 · 2012: 11
FWCI
5.61
Type
journal article
Language
en
Open access
Locations
  • Annals of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Suomen Kulttuurirahasto
  • Turun Yliopistollinen Keskussairaala
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
warfarin, drug interactions, bleeding risk, concomitant medications, nonsteroidal anti-inflammatory drugs, COX-2 inhibitors, selective serotonin reuptake inhibitors, antiplatelet agents, hospitalized patients, anticoagulation
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, Antidepressive Agents, Aryl Hydrocarbon Hydroxylases, Drug Interactions, Enzyme Inhibitors, Female, Finland, Hemorrhage, Hospitalization, Hospitals, University, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Warfarin, Case-Control Studies, Databases, Factual, Young Adult, Cytochrome P-450 CYP2C9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review